Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study

INTRODUCTION: Chimeric antigen receptor T-cell (CAR T) therapy offers a potentially curative option for patients with relapsed and refractory hematologic malignancies, including diffuse large B-cell lymphoma (DLBCL). Patient-reported experiences with CAR T therapy are limited and have not been well...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Rebecca, Scippa, Kayla, Locke, Frederick L., Snider, Julia Thornton, Jim, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590924/
https://www.ncbi.nlm.nih.gov/pubmed/34778941
http://dx.doi.org/10.1007/s40487-021-00174-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590924/
https://www.ncbi.nlm.nih.gov/pubmed/34778941
http://dx.doi.org/10.1007/s40487-021-00174-0

Ejemplares similares